Frontier Ip Share Discussion Threads

[best1467] 28/10/2021 16:10

I've banged on about Pulsiv for a number of years the potential is Humongous and the holding Is around 20% from memory

[someuwin] 28/10/2021 12:13

Thanks - looks like there's tons of hidden value yet to be realised here

[acuere] 28/10/2021 12:09

Pulsiv value £4.08m.
The Vaccine Group is £4.54m.

“We are confident Exscientia's successful IPO is a foretaste of future success", is another quote to whet the appetite.

[someuwin] 28/10/2021 11:21

...What valuation are they currently putting on Pulsiv? It does look amazing if it does what they claim.

[acuere] 28/10/2021 10:55

Yes stellar set of figures.
Worth noting that within that 30 Jun portfolio valuation of £31.98m, Exscientia was valued at £13.3m. At the IPO price it was valued at £25m.

Lots of forward comments to like about the core companies. I’ll just highlight one for now. Pulsiv looks like it could provide next catalyst for share price rise.

“(Pulsiv)̷0;.. will become a major green technology business.
Its unique technology improves the efficiency of electricity conversion meaning devices waste much less energy than conventional techniques. If widely adopted, it means electricity grids can generate less electricity to meet the demand from devices and appliances. It can be used in virtually all mains-powered devices and has a host of other applications.. . . . and is now in advanced discussions with a number of major companies about integrating it into their devices.”

[petewy] 28/10/2021 10:11

Healthy results

Financial highlights
Fair value of our equity portfolio increased by 64% to £31,982,000 (2020: £19,444,000)
· Profit before tax increased by 145% to £10,242,000 (2020: £4,184,000)
Total revenue and other operating income increased by 99% to £12,668,000 (2020: £6,377,000) -reflecting the net unrealised profit on the revaluation of investments of £12,306,000 (2020: £5,973,000)
· Revenue from services decreased by 10% to £362,000 (2020: £404,000)
· Basic earnings per share increased to 17.47p (2020: 8.76p)
· Cash balances at 30 June 2021 of £1,992,000 (2020: £2,968,000)

[acuere] 20/10/2021 13:08

Not sure what the market is expecting from the results due early November. Last guidance from company was 28th April when they said this :-

“we anticipate that the outcome for the year will be materially ahead of management expectations and we look forward to the remainder of the financial year and beyond with optimism."
At that time share price was 81p. Clearly there have been significantly positive events for the portfolio since then and share price is roughly 50% ahead.The question is, how aware is the wider market of the progress that’s been made?

[acuere] 15/10/2021 12:20

I liked these lines from a couple of the portfolio companies.

“Nandi(Proteins)has attracted strong interest from major companies, and will be looking to sign heads of agreement with licensing partners in the coming months.”

And from CamGraphic
“……;… with the technology having attracted significant interest from major companies in the sector.”

[acuere] 15/10/2021 11:02

The newsletter is worth a read.

[acuere] 08/10/2021 16:33

It was only when Exscientia was floated that we got to see the true worth of that holding (4 times book value). Frontier have 18 other holdings, most of which will in the real world be worth much more than the current stated NAV. Obviously they are not all advanced as Exscientia, but at least 3 o4 4 of them aren’t far behind.

[best1467] 08/10/2021 16:04

It's ridiculously undervalued and I don't need anyone to tell me it's blatantly obvious anyone with a mediu. Term investment strategy will do extremely well at these levels

[cordwainer] 08/10/2021 15:09

If a single holding such as Exscientia can boost the NAV by as much as 37p then probably still cheap for an actual investor.

[tizo100] 08/10/2021 14:55

Does he say if they are still cheap?

[metis20] 08/10/2021 10:52

Yes ST picked up on those two fund raises and is particularly excited by The Vaccine Group.

[acuere] 08/10/2021 10:39

So according to ST in that article, thanks to Exscintia the NAV is now at least 91p (56.8p at 31st Dec). I’m not able to read full article but I assume he would pick up on the fact that both Pulsar and CamGraphic have had a recent fundraising which should also increase the NAV.
It’s also worth noting that Pulsar, The Vaccine Group, Nandi Proteins have appointed new CEOs recently and Pulsar also a new CFO. Which would suggest things are stepping up.
I’m assuming Final Results will be out around 5th Nov again and we may see more comment off the back of them.

[tizo100] 08/10/2021 08:35

https://www.investorschronicle.co.uk/ideas/2021/10/07/uncovering-hidden-value/

[slicethepie] 07/10/2021 21:44

More so our gutter press. A fantastic achievement for Oxford, the uk, fipp. They would rather report on the length of a queue at a petrol station than a genuine success story.

[metis20] 07/10/2021 18:48

ST's IC update on FIPP - maybe you have to be logged in to read it - came out about 4 hours ago.

[b3rt1e] 07/10/2021 10:20

It beggars belief that the brokers have not written or commented on such a significant event.

[cordwainer] 06/10/2021 16:24

Upcoming finals will be behind significant recent events but I think the NAV ps must be at least 95p as of today. Gone fishing in today's red sea with a small top-up @ 102.7p.
Chart scenario with downside targets of ~90p and ~80p now seem unlikely against fundamentals.

[best1467] 05/10/2021 07:02

Pulsiv as potential Far Exceeding any other stake

[acuere] 03/10/2021 09:32

A piece from Simon Thompson in the IC last March. Good insight into some of the portfolio and looking at Exscientia it shows what a lowball figure some of the valuations are.

[acuere] 02/10/2021 13:00

Absolutely slicethepie. Investors really should look at Frontiers website and the presentations to see the progress the portfolio of companies are making. The percentage holdings (17% - 43%) are also a lot more significant than the 2.4% in Exscientia. Whilst they may not reach Exscientia IPO value, it’s easy to see a few of these coming to market with £100m+ valuations.
The only other thing I should of said is we don’t know if Fipp sold any shares yesterday. I would assume they would cash in some if not all the holding.

[metis20] 02/10/2021 10:20

Thanks acuere - just spotted the piece on FIPP via your link in the STOCK WATCH column.